Rhode Island Code of Regulations
Title 216 - Department of health
Chapter 60 - Laboratories and Medical Examiner
Subchapter 05 - State Laboratory
Part 6 - Licensing Analytical Laboratories for Sampling and Testing Cannabis
Section 216-RICR-60-05-6.23 - Test Reporting

Current through September 18, 2024

A. Analytical laboratories must report all testing results including all information necessary to determine product compliance to the Department of Business Regulation Cannabis Tracking System and the cannabis producer including registered compassion centers and licensed cultivators.

B. Include the following in the laboratory data package: case narrative, chains-of-custody, and summary of analytical results.

1. A case narrative written on laboratory letterhead, must describe any sample receipt, preparation, or analytical issues encountered as well as any method non-conformances or exceedance of QA/QC criteria used by the laboratory. The narrative must identify the preparation and analytical methods utilized by the laboratory. The narrative must include a signed statement by an authorized laboratory representative as to the accuracy, completeness, and compliance with the methods of the results presented.

2. Chains-of-custody (COC) information or other paperwork indicating requested analyses and documentation of sample collection and receipt must be reported with the laboratory's results.

3. Laboratory reports must clearly identify the name, address, and license number of the laboratory (which may be a subcontracted laboratory) that performed the test(s), and must include the results and the date of the reporting.

4. Multipage reports must be paginated.

5. Summary of analytical results including sample identifier, methods performed, target compounds, sample result or reporting limit, proper qualifier according to laboratory standard procedures, units of measure, preparation date(s), where applicable, and analysis date(s).

6. Analytical results, which exceed the upper limit described in §§ 6.21(D)(2), 6.21(E)(3), 6.21(F)(1), 6.21(G)(2), and 6.21(H)(3) of this Part must be reported with a qualifier indicating the contaminant measured in the cannabis product is above the allowable concentration.

7. The laboratory data package must include sufficient data to evaluate the laboratory results, including a summary of laboratory QA/QC results.

8. Cannabis products, which are determined to be out of compliance may be resampled for follow-up testing. A production batch may be retested once and records of the original analysis must be retained.

Disclaimer: These regulations may not be the most recent version. Rhode Island may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.